# Multilevel determinants of illness since birth among infants aged 5–9 weeks in Ethiopia: Evidence from the 6-week follow-up of the PMA-ethiopia longitudinal survey (2021–2023)

**Authors:** Amare Mebrat Delie, Mickiale Hailu, Molla Getie Mehari, Gizachew Kassahun Bizuneh, Berihun Agegn Mengistie, Tesfaye Shumet Mekonnen, Jianhong Zhou, Orvalho Augusto, Orvalho Augusto

PMC · DOI: 10.1371/journal.pone.0342776 · PLOS One · 2026-02-26

## TL;DR

This study identifies factors influencing early infant illness in Ethiopia, showing that maternal health and bed net ownership are linked to higher illness rates in infants.

## Contribution

The study provides new evidence on multilevel determinants of infant illness in Ethiopia using longitudinal survey data.

## Key findings

- 34.42% of infants aged 5–9 weeks experienced illness since birth.
- Female infants had lower odds of illness compared to males.
- Maternal pregnancy and postpartum complications increased infant illness risk.

## Abstract

Infant illness in the early weeks of life remains a major public health concern in Ethiopia, contributing to neonatal and infant morbidity and mortality. Identifying individual- and community-level determinants is critical to guide targeted interventions.

To assess multilevel determinants of illness since birth among infants aged 5–9 weeks in Ethiopia using data from the PMA-Ethiopia Longitudinal Survey (2021–2023).

We analyzed data from 1,960 infants and mothers enrolled in Cohort 2 of the PMA Ethiopia longitudinal survey, conducted across Addis Ababa, Amhara, Oromia, and SNNP regions. A multistage stratified cluster design with sampling weights ensured national representativeness. The outcome was any maternal-reported infant illness since birth. Multilevel binary logistic regression accounted for clustering within mothers and enumeration areas. Adjusted odds ratios with 95% confidence intervals were reported, and model fit was compared using AIC and BIC.

Overall, 34.42% (95% CI: 30.23–38.87) of infants experienced illness since birth, while 65.58% (95% CI: 61.13–69.77) remained illness-free. Female infants had lower odds of illness than male infants (AOR = 0.53; 95% CI: 0.35–0.82). Infants born to mothers who experienced pregnancy complications had higher odds of illness (AOR = 1.89; 95% CI: 1.11–3.20), as did infants of mothers with postpartum complications (AOR = 2.33; 95% CI: 1.27–4.27). Infants from households owning insecticide-treated bed nets also had higher odds of illness (AOR = 1.81; 95% CI: 1.10–2.96).

About one-third of Ethiopian infants experienced illness within 5–9 weeks of life. Female infants were less vulnerable, whereas maternal complications during pregnancy and postpartum markedly increased illness risk. The association with bed net ownership warrants further investigation. Strengthening maternal health services and targeted interventions may reduce early infant morbidity.

## Full-text entities

- **Genes:** OPRM1 (opioid receptor mu 1) [NCBI Gene 4988] {aka LMOR, M-OR-1, MOP, MOR, MOR1, OPRM}
- **Diseases:** jaundice (MESH:D007565), diarrhea (MESH:D003967), Pneumonia (MESH:D011014), fetal acute and lung disease (MESH:D005315), skin rash or lesions (MESH:D005076), neonatal sepsis (MESH:D000071074), gestational diabetes (MESH:D016640), bleeding (MESH:D006470), vomiting (MESH:D014839), convulsions (MESH:D012640), endometritis (MESH:D004716), Fever (MESH:D005334), respiratory distress (MESH:D012128), food (MESH:D005517), blurred (MESH:D014786), ID (MESH:C537985), ARI (MESH:D012141), headaches (MESH:D006261), complication (MESH:D008107), intrauterine growth restriction (MESH:D005317), edema (MESH:D004487), labor (MESH:D048949), failure (MESH:D051437), unconsciousness (MESH:D014474), food insufficiency (MESH:D000309), prematurity (MESH:C536271), neonatal (MESH:D007232), Tetanus (MESH:D013746), sepsis (MESH:D018805), illness (MESH:D002908), infectious diseases (MESH:D003141), malaria (MESH:D008288), Intimate partner violence (MESH:C563733), intestinal worm infections (MESH:D007410), hypertensive disorders (MESH:D006973), neonatal jaundice (MESH:D007567), PMA (MESH:D009207), deaths (MESH:D003643), sore throat (MESH:D010612), neonatal death (MESH:D066087), pregnancy complication (MESH:D011248), anemia (MESH:D000740), hypothermia (MESH:D007035), ARI symptoms (MESH:D012818), cough (MESH:D003371), lethargy (MESH:D053609), premature membrane rupture (MESH:D005322), perinatal asphyxia (MESH:D001237), chest indrawing (MESH:D013898), infant illness (MESH:D007235), preterm birth (MESH:D047928), cold (MESH:D000067390), infections (MESH:D007239), hypoglycemia (MESH:D007003), gastrointestinal diseases (MESH:D005767)
- **Chemicals:** testosterone (MESH:D013739), iron (MESH:D007501), oxygen (MESH:D010100), steroid (MESH:D013256), BIC (-), magnesium sulfate (MESH:D008278)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12944765/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12944765/full.md

## References

54 references — full list in the complete paper: https://tomesphere.com/paper/PMC12944765/full.md

---
Source: https://tomesphere.com/paper/PMC12944765